Search results
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 21 hours agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 20 hours agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Gateway - Quartz
Quartz· 13 hours agoModerna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of Health-System Pharmacists said ...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 1 day agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Wellington Management Group LLP
ETF DAILY NEWS· 1 day agoWellington Management Group LLP lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.8% in the 4th quarter, according to the company in its most ...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 2 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Moderna stock is lone omen of bird flu pandemic
Reuters· 22 hours agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 1 day agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the...
Simply Wall St. via Yahoo Finance· 4 days agoLong term investing can be life changing when you buy and hold the truly great businesses. And...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 6 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...